ArticleJournal of diabetes investigation2026

Safety of anagliptin/metformin combination tablets evaluated by non-inferiority between pre- and post-serum lactic acid levels in Japanese patients with type 2 diabetes and moderate renal impairment (AMELIO STUDY).

Hiroshi Kajio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.